Cancer Services Pharmacist Questionnaire Data

Data description: A dataset of all patients reported to have an interaction with a Cancer Services Pharmacist (CSP) between the 1st January 2021 and 28th of February 2022 was provided by the tertiary teaching hospital in Western Australia in March 2022. The original dataset included 1528 records and, after removing duplicates, 512 records remained. A randomiser (www.randomizer.org) was used to generate a random sample of 300 patients. Deceased patients (n = 58) were removed and a questionnaire, a patient information sheet and a reply-paid envelope was sent via Australia Post to the remaining patients on 18th March 2022. Patients who were taking at least one oral antineoplastic agents (OAA) and were living, were considered eligible for this study. Patients were excluded if they were receiving exclusive IV chemotherapy or sub-cutaneous injections or were under the age of 18 years. Of the 242 patient sample, 54 patients were excluded due to not meeting the inclusion criteria. Reasons for exclusion included not taking an OAA (n=42), no record of a consult with the CSP (n=5), duplicate patients (n=4), under the age of 18 (n=1) or their consult was outside the investigation period (n=2). Data on all 188 eligible patients was collected using the electronic medical records database at the hospital. The response rate to the questionnaire was 27.7% (52/ 188).
Number of files/types: 1 xlsx file
Special software required to open files: Excel
Geographic information (if relevant): Western Australia
Keywords: cancer services pharmacist, cancer clinic, oral antineoplastic agent, Australia